Cytogenetic bio-indicators and their implications in biomonitoring individuals exposed to chronic and low doses of ionising radiation Online publication date: Fri, 15-Aug-2008
by Hossein Mozdarani
International Journal of Low Radiation (IJLR), Vol. 5, No. 2, 2008
Abstract: Radiation cytogenetics has benefited from recent developments in genetics and molecular biology to develop biomarkers and methods for radiation dose assessment. Regarding the widespread usage of nuclear technology in industry and medicine, only about 450 registered radiological and nuclear accidents throughout the world indicate that limited number of individuals were exposed to acute doses of ionising radiation during the last 50 years. On the other hand, a large population working in these facilities or residing in high natural radiation background areas are chronically exposed to long-term low-dose ionising radiation. However, most of the efforts are devoted to identifying a suitable biomarker and method for the assessments of exposure to acute doses of ionising radiation. In this mini-review, the current widely used methods and biomarkers are explained, with a special focus on translocations as suitable biomarkers for the biomonitoring of cumulative exposures in light of the recent advent of molecular cytogenetics technology.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Low Radiation (IJLR):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook